CA Stock MarketDetailed Quotes

DTC Defence Therapeutics Inc

Watchlist
  • 0.790
  • -0.100-11.24%
15min DelayMarket Closed Apr 24 10:34 ET
43.23MMarket Cap-8.78P/E (TTM)

About Defence Therapeutics Inc Company

Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development. It operates only in Canada.

Company Profile

SymbolDTC
Company NameDefence Therapeutics Inc
Founded2017
MarketCNQ
Employees2
Fiscal Year Ends06-30
Address200 Burrard Street Suite 1680
CityVancouver
CountryCAN
Zip CodeV6C3L6
Phone+1 514 947-2272

Company Executives

  • Name
  • Position
  • Salary
  • Simon Beaudoin
  • CTSO and Accum Co-Founder
  • --
  • Sebastien Plouffe
  • CEO and Director
  • --
  • Joseph Meagher
  • CFO and Director
  • --
  • Raimar Lobenberg
  • Chairman of the Board
  • --
  • Sarkis Meterissian
  • Director
  • --
  • Moutih Rafei
  • VP Research and Development and Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More